重组Anti-EIF2B1抗体[EPR13894(B)] - BSA and Azide free
Anti-EIF2B1 antibody [EPR13894(B)] - BSA and Azide free
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal EIF2B1 antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 1 publication.
查看别名
EIF2BA, EIF2B1, Translation initiation factor eIF2B subunit alpha, eIF2B GDP-GTP exchange factor subunit alpha
- WB
Supplier Data
Western blot - Anti-EIF2B1 antibody [EPR13894(B)] - BSA and Azide free (AB250411)
This data was developed using ab181186, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-EIF2B1 antibody [EPR13894(B)] (<a href='/products/primary-antibodies/eif2b1-antibody-epr13894b-ab181186'>ab181186</a>) at 1/10000 dilution
Lane 1:
SH-SY5Y cell lysate at 20 µg
Lane 2:
Jurkat cell lysate at 20 µg
Lane 3:
MCF7 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 34 kDa
Observed band size: 34 kDa
false
- WB
Supplier Data
Western blot - Anti-EIF2B1 antibody [EPR13894(B)] - BSA and Azide free (AB250411)
This data was developed using ab181186, the same antibody clone in a different buffer formulation.
Immunoprecipitation. ab181186 at 1/1000 labeling elF2B1 immunoprecipitated from MCF7 cell lysate using ab181186 at 1/50.
All lanes:
Western blot - Anti-EIF2B1 antibody [EPR13894(B)] (<a href='/products/primary-antibodies/eif2b1-antibody-epr13894b-ab181186'>ab181186</a>)
Predicted band size: 34 kDa
Observed band size: 34 kDa
false
不同偶联物与剂型 (1)
-
Anti-EIF2B1 antibody [EPR13894(B)]
反应性数据
产品详情
ab250411 is the carrier-free version of ab181186.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF2B1 regulates protein synthesis by modulating the activity of the eIF2B complex which is a guanine nucleotide exchange factor. This complex comprises five subunits and EIF2B1 is integral for its function. Through regulation of eIF2 EIF2B1 indirectly controls the rate of translation initiation affecting cell growth and stress response mechanisms. In neurons EIF2B1’s activity influences neuronal development and maintenance.
Pathways
EIF2B1 functions prominently in both the unfolded protein response and integrated stress response pathways. These pathways respond to cellular stress by altering translation rates and are essential for maintaining protein homeostasis. EIF2B1 interacts primarily through these pathways with other proteins such as eIF2 and ATF4 which is a transcription factor activated during stress responses.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (1)
Recent publications for all applications. Explore the full list and refine your search
Evidence-based complementary and alternative medicine : eCAM 2022:7757833 PubMed36091585
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com